Clinical Trials Logo

Hyperbaric Oxygen clinical trials

View clinical trials related to Hyperbaric Oxygen.

Filter by:
  • None
  • Page 1

NCT ID: NCT04297358 Completed - Stroke Clinical Trials

Hyperbaric Oxygen in Patients Who Had a Stroke

HOST
Start date: December 20, 2017
Phase: Phase 4
Study type: Interventional

Prospective clinical assessment of 40 Hyperbaric Oxygen (HBO) treatments in 10 completed stroke patients.

NCT ID: NCT04129983 Not yet recruiting - Clinical trials for Hearing Loss, Sudden

Treatment of Sudden Deafness With Prednisone+Hyperbaric Oxygen and Prednisone+Somatosensory Stimulation

Start date: June 2020
Phase: N/A
Study type: Interventional

To study the effective treatment of sudden deafness by giving prednisone, hyperbaric oxygen and somatosensory stimulation to sudden deafness patients.

NCT ID: NCT03325959 Completed - Fibromyalgia Clinical Trials

Hyperbaric Oxygen Compared to Pharmaceutical Therapies for Fibromyalgia Syndrome

FMSRCT
Start date: March 1, 2017
Phase: N/A
Study type: Interventional

The investigators have previously studied the efficacy of hyperbaric oxygen therapy (HBOT) as a treatment for Fibromyalgia syndrome (FMS) in a prospective, active control, crossover clinical trial. The results demonstrated significant amelioration of all FMS symptoms, with significant improvement in life quality; furthermore, the investigators were able to demonstrate significant neuroplasticity on SPECT imaging, with a decrease of the hyperactivity in posterior regions and elevation of the reduced activity in frontal areas. In the proposed study, the investigators intend to both repeat and expand our previous findings, treating FMS patients with HBOT while performing an extensive of evaluation both before and after treatment. In the current study, the investigators plan to compare HBOT to current standard of care of FMS (pharmacological and non - pharmacological).